Schonfeld Strategic Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Schonfeld Strategic Advisors's ALT Position: Q2 2026 in Review
Schonfeld Strategic Advisors opened a new position in Altimmune (ALT) in Q2 2026: 35,077 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2299 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in ALT as recently as Q4 2025.
Schonfeld Strategic Advisors first reported a position in ALT in Q2 2020 and has held it in 14 quarters since. The position peaked at $2.09M in Q2 2022. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Schonfeld Strategic Advisors held 35,077 shares of Altimmune worth $107K as of Q2 2026.
- Altimmune was a new Schonfeld Strategic Advisors position in Q2 2026.
- Altimmune made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2299 holding.
- Schonfeld Strategic Advisors first reported a position in Altimmune in Q2 2020 and has held it in 14 quarters since.
- Schonfeld Strategic Advisors's Altimmune position peaked at $2.09M in Q2 2022.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.